Abstract:Chronic endometriosis (CE) is a chronic infectious disease that is often misdiagnosed due to its vague symptomatic severity, lack of typical clinical or ultrasounds symptoms, and requirement for histopathologic diagnosis. Evidence has shown that CE may be associated with various subgroups of reproductive failure. Diagnosis of CE relies on identification of plasma cells in the endometrial stroma in addition to measurement of expression of syndecan-1 (CD138), a transmembrane heparin sulfate proteoglycan expressed in plasma cells. Despite this, uncertainty among experts exists whether CD138-positive cell count provides a robust marker of CE.This retrospective analysis aimed to evaluate the predictive value of a positive CD138 cell count on clinical pregnancy outcome and implantation rate. Patients were included that had previously failed the transfer of 2 high-quality fresh embryos and who then underwent endometrial biopsy on day 7 after ovulation in the natural cycle preceding frozen embryo transfer. Paraffin-embedded endometrial biopsy samples were obtained, sectioned, and stained using a mouse monoclonal antibody against CD138. A CD138-positive cell count was then obtained, and receiver operating characteristic (ROC) curves were produced to analyze the relationship between CD138 and clinical pregnancy outcomes. Subgroups were created for stratifying CD138 expression, with subgroup 1 containing patients with CD138-positive count of 0, subgroup 2 had a CD138-positive count of 1 to 5, and subgroup 3 had a CD138-positive count of greater than 5.The final study cohort included 141 women seen at the Reproductive and Genetic Hospital of CITIC-Xiangya between December 2016 and July 2018. Of the 141 women, 44 (31.2%) were positive for CD138 expression. The patients with a normal CD138 count had a significantly greater rate of pregnancy and embryo implantation compared with the CD138-positive group. Receiver operating characteristic curves based on CD138-positive cell count and CD138-positive cell density were 0.658 and 0.660, respectively. The clinical pregnancy rates in subgroups 1, 2, and 3 were 80.4%, 60.6%, and 27.3%, respectively (P = 0.001), and the embryo implantation rates were 64.9%, 53.1%, and 26.7%, respectively (P = 0.01). After multivariate logistic regression analysis, it was found that free pelvic fluid on the day of endometrial sampling was a risk factor for CD138-positive cell count (P = 0.011; odds ratio, 6.422; 95% confidence interval, 1.287-7.200).These results indicate that the presence of CD138-expressing cells is predictive of pregnancy outcome after frozen embryo transfer in patients with normal endometrial dating and histopathologic features that had previously failed the transfer of 2 high-quality embryos. There was considerable difference in embryo implantation and achievement of clinical pregnancy between the CD138-positive and CD138-negative cohorts. A higher CD138-positive cell count was associated with poorer pregnancy outcomes, indicating testing CD138 levels may be valuable when discussing success rate with in vitro fertilization.

Effect on pregnancy outcome of women screening chronic endometritis by CD38 and CD138 before frozen-thawed embryo transfer

Antibiotics improve reproductive outcomes after frozen-thaw embryo transfer for chronic endometritis treatment, especially in those with repeated implantation failure

Effect on Pregnancy Outcome of Hysteroscopy Combined with Chronic Endometritis Screening Before the Next Frozen-Thawed Embryo Transfer in Patients with Previous Failed Transfer Cycle

Impact of Oral Antibiotic Treatment for Chronic Endometritis on Pregnancy Outcomes in the Following Frozen-Thawed Embryo Transfer Cycles of Infertile Women: a Cohort Study of 640 Embryo Transfer Cycles.

Impact of Antibiotic Cured Chronic Endometritis on Perinatal Outcomes: Re-evaluation of a Cohort Study with a Detailed Follow-Up

The Effect of Chronic Endometritis and Treatment on Patients with Unexplained Infertility

Effect of Different Antibiotic Therapies on the Reproductive Outcomes of Fresh Embryo Transfer for Chronic Endometritis: A Retrospective Cohort Study

Antibiotic cured chronic endometritis remains a risk factor for early pregnancy loss in the subsequent frozen-warmed euploid embryo transfer

Exploring the optimal time to screen for chronic endometritis in patients with previous unpregnant embryo transfer cycle

Analysis of Pregnancy Outcomes in Patients with Recurrent Implantation Failure Complicated with Chronic Endometritis

Diagnosis Of Chronic Endometritis: How Many Cd138(+) Cells/Hpf In Endometrial Stroma Affect Pregnancy Outcome Of Infertile Women?

Antibiotic Cured Chronic Endometritis Remains a Risk Factor for Early Pregnancy Loss in the Subsequent Frozen Euploid Embryo Transfer

Impact of Diagnosis and Treatment of Chronic Endometritis on Outcomes Before Starting Assisted Reproductive Technology: A Retrospective Study

Endometrial Cd138 Count Appears To Be A Negative Prognostic Indicator For Patients Who Have Experienced Previous Embryo Transfer Failure

Antibiotics combined with vaginal probiotics in the embryo transfer cycle of infertile patients with chronic endometritis

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Correlation of hysteroscopic findings of chronic endometritis with CD138 immunohistochemistry and their correlation with pregnancy outcomes

The endometrial preparation protocol had no impact on pregnancy outcomes in frozen embryo transfer cycles of patients with cured chronic endometritis

Chronic endometritis impairs embryo implantation in patients with repeated implantation failure: A retrospective study

Effect of Endometrial Thickness Change in Response to Progesterone Administration on Pregnancy Outcomes in Frozen-Thawed Embryo Transfer: Analysis of 4465 Cycles

Confirmation of chronic endometritis in repeated implantation failure and success outcome in IVF-ET after intrauterine delivery of the combined administration of antibiotic and dexamethasone.